Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 5/20 | 0.50 |
| ▸ | MMP2 | P08253 | 4/20 | 0.50 |
| ▸ | MMP9 | P14780 | 4/20 | 0.50 |
| ▸ | ADAM10 | O14672 | 3/20 | 0.50 |
| ▸ | ADAM8 | P78325 | 3/20 | 0.50 |
| ▸ | MMP14 | P50281 | 3/20 | 0.50 |
| ▸ | MMP12 | P39900 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 2/20 | 0.47 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.47 |
| ▸ | ADAMTS1 | Q9UHI8 | 1/20 | 0.47 |
| ▸ | ADAMTS7 | Q9UKP4 | 1/20 | 0.47 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.47 |
| ▸ | BMP1 | P13497 | 12/20 | 0.47 |
| ▸ | MMP7 | P09237 | 1/20 | 0.45 |
| ▸ | MMP13 | P45452 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1799495 | 0.86 | ADAM17 (0.47) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL4377322 | 0.84 | ADAM17 (0.56) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1802607 | 0.82 | MMP2 (0.52) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1800002 | 0.82 | ADAM17 (0.45) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1800964 | 0.81 | ADAM17 (0.47) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1796851 | 0.76 | ADAM17 (0.59) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL3872450 | 0.76 | MMP13 (0.56) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1800828 | 0.76 | BMP1 (0.51) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL1799177 | 0.75 | BMP1 (0.58) | ADAM17MMP2MMP9ADAM10ADAM8 | |
| SCHEMBL3869082 | 0.75 | MMP2 (0.42) | ADAM17MMP2MMP9ADAM10ADAM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8247451-B2 | ADAM10 and its uses related to infection | VANDERBILT UNIVERSITY (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247451-B2 | ADAM10 and its uses related to infection | VANDERBILT UNIVERSITY (US) | 2012-08-21 | — | — | US | disclosed |
| US-8247451-B2 | ADAM10 and its uses related to infection | VANDERBILT UNIVERSITY (US) | 2012-08-21 | — | — | US | disclosed |
| US-20090220514-A1 | ADAM10 and its Uses Related to Infection | VANDERBILT UNIVERSITY | 2009-09-03 | — | — | US | disclosed |
| US-20090220514-A1 | ADAM10 and its Uses Related to Infection | VANDERBILT UNIVERSITY | 2009-09-03 | — | — | US | disclosed |
| US-20090220514-A1 | ADAM10 and its Uses Related to Infection | VANDERBILT UNIVERSITY | 2009-09-03 | — | — | US | disclosed |
| WO-2007084488-A2 | ADAM10 AND ITS USES RELATED TO INFECTION | VANDERBILT UNIVERSITY (US) | 2007-07-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220514-A1 | ADAM10 and its Uses Related to Infection | ADAM10, ADAM12, ADAM17 | ADAM17 3/4885MMP2 223/4885MMP9 97/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.